Novo Nordisk A/S (NVO) has risen Thursday morning, with the stock increasing 0.85% in pre-market trading to 104.51. NVO's short-term technical score of 89 indicates that the stock has traded more bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 98% of stocks. Novo Nordisk A/S has risen 16.09% over the past month, closing at $91.37 on July 29. During this period of time, the stock fell as low as $91.37 and as high as $107.24. NVO has an average analyst recommendation of Buy. The company has an average price target of $106.55.
NVO has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on NVO!